Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines

Antigen-specific immunotherapy using DNA vaccines has emerged as an attractive approach for the control of tumors. Another novel cancer therapy involves the employment of the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA). In the current study, we aimed to test the combinati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Peng, Shiwen, Monie, Archana, Pang, Xiaowu, Hung, Chien-Fu, Wu, T-C
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3062584/
https://ncbi.nlm.nih.gov/pubmed/21385449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1423-0127-18-21
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars